12
Participants
Start Date
February 28, 2011
Primary Completion Date
March 31, 2013
Study Completion Date
May 31, 2013
lanthanum carbonate
FOSRENOL® will be administered orally in a dose of 1500- 3750 mg daily in divided doses with meals. Dose escalation will be utilized to a target dose of 3750 mg daily or as designated by clinician over a 4-week period from start of study. The drug will be administered for 12 weeks.
Lanthanum for calciphylaxis
Lanthanum use in calciphylaxis
University of Wisconsin Hospitals, Madison
Collaborators (1)
Shire
INDUSTRY
University of Wisconsin, Madison
OTHER